Skip to main content
Institute for Global Health & Infectious Diseases

2016

 

  1. Chawla KS, Kanyama C, Mbewe A, et al. Policy to practice: impact of GeneXpert MTB/RIF implementation on the TB spectrum of care in Lilongwe, Malawi. Trans R Soc Trop Med Hyg 2016; 110(5): 305-11.
  2. Shivakoti R, Yang WT, Berendes S, et al. Persistently Elevated C-Reactive Protein Level in the First Year of Antiretroviral Therapy, Despite Virologic Suppression, Is Associated With HIV Disease Progression in Resource-Constrained Settings. J Infect Dis 2016; 213(7): 1074-8.
  3. Shivakoti R, Christian P, Yang WT, et al. Prevalence and risk factors of micronutrient deficiencies pre- and post-antiretroviral therapy (ART) among a diverse multicountry cohort of HIV-infected adults. Clinical nutrition 2016; 35(1): 183-9.
  4. Balagopal A, Gupte N, Shivakoti R, et al. Continued Elevation of Interleukin-18 and Interferon-gamma After Initiation of Antiretroviral Therapy and Clinical Failure in a Diverse Multicountry Human Immunodeficiency Virus Cohort. Open forum infectious diseases 2016; 3(3): ofw118.
  5. Barlow-Mosha L, Angelidou K, Lindsey J, et al. Nevirapine- Versus Lopinavir/Ritonavir-Based Antiretroviral Therapy in HIV-Infected Infants and Young Children: Long-term Follow-up of the IMPAACT P1060 Randomized Trial. Clin Infect Dis 2016; 63(8): 1113-21.
  6. Parr JB, Belson C, Patel JC, et al. Estimation of Plasmodium falciparum Transmission Intensity in Lilongwe, Malawi, by Microscopy, Rapid Diagnostic Testing, and Nucleic Acid Detection. Am J Trop Med Hyg 2016; 95(2): 373-7.
  7. Sims Sanyahumbi A, Sable CA, Beaton A, et al. School and Community Screening Shows Malawi, Africa, to Have a High Prevalence of Latent Rheumatic Heart Disease. Congenit Heart Dis 2016.
  8. Gallaher JR, Haac BE, Geyer AJ, Mabedi C, Cairns BA, Charles AG. Injury Characteristics and Outcomes in Elderly Trauma Patients in Sub-Saharan Africa. World J Surg 2016; 40(11): 2650-7.
  9. Young S, Banza L, Munthali BS, Manda KG, Gallaher J, Charles A. The impact of the increasing burden of trauma in Malawi on orthopedic trauma service priorities at Kamuzu Central Hospital. Acta orthopaedica 2016; 87(6): 632-6.
  10. Shah M, Gallaher J, Msiska N, McLean SE, Charles AG. Pediatric intestinal obstruction in Malawi: characteristics and outcomes. Am J Surg 2016; 211(4): 722-6.
  11. Gallaher JR, Wildfire B, Mabedi C, Cairns BA, Charles AG. Intentional injury against children in Sub-Saharan Africa: A tertiary trauma centre experience. Injury 2016; 47(4): 837-41.
  12. Boschini LP, Lu-Myers Y, Msiska N, Cairns B, Charles AG. Effect of direct and indirect transfer status on trauma mortality in sub Saharan Africa. Injury 2016; 47(5): 1118-22.
  13. Bane M, Kaima R, Mapala S, Cairns B, Charles A. Qualitative evaluation of paediatric burn injury in Malawi: assessing opportunities for injury prevention. Trop Doct 2016; 46(3): 165-7.
  14. Barnett BS, Mulenga M, Kiser MM, Charles AG. Qualitative analysis of a psychological supportive counseling group for burn survivors and families in Malawi. Burns : journal of the International Society for Burn Injuries 2016.
  15. Gutnik L, Lee C, Msosa V, et al. Clinical breast examination screening by trained laywomen in Malawi integrated with other health services. J Surg Res 2016; 204(1): 61-7.
  16. Gutnik L, Moses A, Stanley C, Tembo T, Lee C, Gopal S. From Community Laywomen to Breast Health Workers: A Pilot Training Model to Implement Clinical Breast Exam Screening in Malawi. PLoS One 2016; 11(3): e0151389.
  17. Rutstein SE, Pettifor AE, Phiri S, et al. Incorporating Acute HIV Screening into Routine HIV Testing at Sexually Transmitted Infection Clinics, and HIV Testing and Counseling Centers in Lilongwe, Malawi. J Acquir Immune Defic Syndr 2016; 71(3): 272-80.
  18. Rutstein SE, Golin CE, Wheeler SB, et al. On the front line of HIV virological monitoring: barriers and facilitators from a provider perspective in resource-limited settings. AIDS Care 2016; 28(1): 1-10.
  19. Barnett BS, Chaweza T, Tweya H, Ngambi W, Phiri S, Hosseinipour MC. Assessment of non-standard HIV antiretroviral therapy regimens at Lighthouse Trust in Lilongwe, Malawi. Malawi Med J 2016; 28(1): 6-9.
  20. Mathad JS, Gupte N, Balagopal A, et al. Sex-related Differences in Inflammatory and Immune Activation Markers before and after combined Antiretroviral Therapy Initiation. J Acquir Immune Defic Syndr 2016.
  21. La Rosa AM, Harrison LJ, Taiwo B, et al. Raltegravir in second-line antiretroviral therapy in resource-limited settings (SELECT): a randomised, phase 3, non-inferiority study. The lancet HIV 2016; 3(6): e247-58.
  22. Flick RJ, Kim MH, Simon K, et al. Burden of disease and risk factors for death among children treated for tuberculosis in Malawi. Int J Tuberc Lung Dis 2016; 20(8): 1046-54.
  23. Hosseinipour MC, Bisson GP, Miyahara S, et al. Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trial. Lancet 2016; 387(10024): 1198-209.
  24. Chagomerana MB, Miller WC, Pence BW, et al. PMTCT Option B+ does not increase preterm birth risk and may prevent extreme prematurity: A retrospective cohort study in Malawi. J Acquir Immune Defic Syndr 2016.
  25. Kourtis AP, Haddad L, Tang J, et al. A randomized clinical trial on the effects of progestin contraception in the genital tract of HIV-infected and uninfected women in Lilongwe, Malawi: Addressing evolving research priorities. Contemp Clin Trials 2016; 52: 27-34.
  26. Kohler RE, Tomlinson J, Chilunjika TE, Young S, Hosseinipour M, Lee CN. “Life is at a standstill” Quality of life after lower extremity trauma in Malawi. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2016.
  27. Flax VL, Hamela G, Mofolo I, Hosseinipour MC, Hoffman I, Maman S. Infant and Young Child Feeding Counseling, Decision-Making, and Practices Among HIV-Infected Women in Malawi’s Option B+ Prevention of Mother-to-Child Transmission Program: A Mixed Methods Study. AIDS Behav 2016; 20(11): 2612-23.
  28. Matoga MM, Hosseinipour MC, Aga E, et al. Hyperlipidaemia in HIV-infected patients on lopinavir/ritonavir monotherapy in resource-limited settings. Antivir Ther 2016.
  29. Tang JH, Phiri S, Ng’ambi W, et al. Factors Associated with Hormonal and Intrauterine Contraceptive Use among HIV-Infected Men and Women in Lilongwe, Malawi: A Cross-Sectional Study. Infect Dis Obstet Gynecol 2016; 2016: 5429316.
  30. Lancaster KE, Lungu T, Mmodzi P, et al. The association between substance use and sub-optimal HIV treatment engagement among HIV-infected female sex workers in Lilongwe, Malawi. AIDS Care 2016: 1-7.
  31. Cohen MS, Chen YQ, McCauley M, et al. Antiretroviral Therapy for the Prevention of HIV-1 Transmission. N Engl J Med 2016; 375(9): 830-9.
  32. Rutstein SE, Hosseinipour MC, Weinberger M, et al. Predicting resistance as indicator for need to switch from first-line antiretroviral therapy among patients with elevated viral loads: development of a risk score algorithm. BMC Infect Dis 2016; 16: 280.
  33. Mathad JS, Gupte N, Balagopal A, et al. Sex-Related Differences in Inflammatory and Immune Activation Markers Before and After Combined Antiretroviral Therapy Initiation. J Acquir Immune Defic Syndr 2016; 73(2): 123-9.
  34. Chiwaula LS, Chirwa GC, Caltado F, et al. The value of informal care in the context of option B+ in Malawi: a contingent valuation approach. BMC Health Serv Res 2016; 16: 136.
  35. Lancaster KE, Go VF, Lungu T, et al. Substance use and HIV infection awareness among HIV-infected female sex workers in Lilongwe, Malawi. The International journal on drug policy 2016; 30: 124-31.
  36. Mave V, Erlandson KM, Gupte N, et al. Inflammation and Change in Body Weight With Antiretroviral Therapy Initiation in a Multinational Cohort of HIV-Infected Adults. J Infect Dis 2016; 214(1): 65-72.
  37. O’Shea MS, Rosenberg NE, Tang JH, et al. Reproductive intentions and family planning practices of pregnant HIV-infected Malawian women on antiretroviral therapy. AIDS Care 2016; 28(8): 1027-34.
  38. Fogel JM, Hudelson SE, Ou SS, et al. Brief Report: HIV Drug Resistance in Adults Failing Early Antiretroviral Treatment: Results From the HIV Prevention Trials Network 052 Trial. J Acquir Immune Defic Syndr 2016; 72(3): 304-9.
  39. Lancaster KE, Powers KA, Lungu T, et al. The HIV Care Continuum among Female Sex Workers: A Key Population in Lilongwe, Malawi. PLoS One 2016; 11(1): e0147662.
  40. Kohler RE, Tang J, Gopal S, et al. High rates of cervical cancer among HIV-infected women at a referral hospital in Malawi. Int J STD AIDS 2016; 27(9): 753-60.
  41. Pettifor A, MacPhail C, Selin A, et al. HPTN 068: A Randomized Control Trial of a Conditional Cash Transfer to Reduce HIV Infection in Young Women in South Africa-Study Design and Baseline Results. AIDS Behav 2016.
  42. Pettifor A, Rosenberg N, Bekker LG. Can cash help eliminate mother-to-child HIV transmission? The lancet HIV 2016; 3(2): e60-2.
  43. Baeten JM, Palanee-Phillips T, Brown ER, et al. Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women. N Engl J Med 2016.
  44. Stanley CC, Westmoreland KD, Heimlich BJ, et al. Outcomes for paediatric Burkitt lymphoma treated with anthracycline-based therapy in Malawi. Br J Haematol 2016; 173(5): 705-12.
  45. Rosenberg NE, Hauser BM, Ryan J, Miller WC. The effect of HIV counselling and testing on HIV acquisition in sub-Saharan Africa: a systematic review. Sex Transm Infect 2016; 92(8): 579-86.
  46. Rosenberg NE. HIV testing to the test: does HIV testing promote HIV prevention in HIV-uninfected adults? Sex Transm Infect 2016; 92(8): 566-7.
  47. Rosenberg NE, Stanley CC, Rutstein SE, et al. Recruiting the social contacts of patients with STI for HIV screening in Lilongwe, Malawi: process evaluation and assessment of acceptability. Sex Transm Infect 2016; 92(8): 587-92.
  48. Rutstein SE, Price JT, Rosenberg NE, Rennie SM, Biddle AK, Miller WC. Hidden costs: The ethics of cost-effectiveness analyses for health interventions in resource-limited settings. Glob Public Health 2016: 1-13.
  49. Sih AM, Kopp DM, Tang JH, et al. Association between parity and fistula location in women with obstetric fistula: a multivariate regression analysis. BJOG 2016; 123(5): 831-6.
  50. Drew LB, Wilkinson JP, Nundwe W, et al. Long-term outcomes for women after obstetric fistula repair in Lilongwe, Malawi: a qualitative study. BMC Pregnancy Childbirth 2016; 16(1): 2.
  51. Tang JH, Kaliti C, Bengtson A, et al. Improvement and retention of emergency obstetrics and neonatal care knowledge and skills in a hospital mentorship program in Lilongwe, Malawi. Int J Gynaecol Obstet 2016; 132(2): 240-3.
  52. Bengtson AM, Kopp D, Tang JH, Chipungu E, Moyo M, Wilkinson J. Identifying Patients With Vesicovaginal Fistula at High Risk of Urinary Incontinence After Surgery. Obstet Gynecol 2016; 128(5): 945-53.
  53. Gopal S, Fedoriw Y, Kaimila B, et al. CHOP Chemotherapy for Aggressive Non-Hodgkin Lymphoma with and without HIV in the Antiretroviral Therapy Era in Malawi. PLoS One 2016; 11(3): e0150445.
  54. Chinula L, Moses A, Gopal S. HIV-associated malignancies in sub-Saharan Africa: progress, challenges, and opportunities. Curr Opin HIV AIDS 2016.
  55. Kohler RE, Gopal S, Miller AR, et al. A framework for improving early detection of breast cancer in sub-Saharan Africa: A qualitative study of help-seeking behaviors among Malawian women. Patient Educ Couns 2016.
  56. Nel A, Bekker LG, Bukusi E, et al. Safety, Acceptability and Adherence of Dapivirine Vaginal Ring in a Microbicide Clinical Trial Conducted in Multiple Countries in Sub-Saharan Africa. PLoS One 2016; 11(3): e0147743.
  57. Balkus JE, Brown ER, Hillier SL, et al. Corrigendum to “oral and injectable contraceptive use and HIV acquisition risk among women in four African countries: a secondary analysis of data from a microbicide trial” [Contraception 2016; 93 (1): 25-31]. Contraception 2016; 94(1): 95.
  58. Balkus JE, Brown ER, Hillier SL, et al. Oral and injectable contraceptive use and HIV acquisition risk among women in four African countries: a secondary analysis of data from a microbicide trial. Contraception 2016; 93(1): 25-31.
  59. Fowler MG, Qin M, Fiscus SA, et al. Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention. N Engl J Med 2016; 375(18): 1726-37.
  60. Kasaro MP, Husnik MJ, Chi BH, et al. Impact of targeted counseling on reported vaginal hygiene practices and bacterial vaginosis: the HIV Prevention Trials Network 035 study. Int J STD AIDS 2016.
  61. Westmoreland KD, Stanley CC, Montgomery ND, et al. Hodgkin lymphoma, HIV, and Epstein-Barr virus in Malawi: Longitudinal results from the Kamuzu Central Hospital Lymphoma study. Pediatr Blood Cancer 2016.
  62. Liu W, Snell JM, Jeck WR, et al. Subtyping sub-Saharan esophageal squamous cell carcinoma by comprehensive molecular analysis. JCI insight 2016; 1(16): e88755.
  63. Montgomery ND, Liomba NG, Kampani C, et al. Accurate Real-Time Diagnosis of Lymphoproliferative Disorders in Malawi Through Clinicopathologic Teleconferences: A Model for Pathology Services in Sub-Saharan Africa. Am J Clin Pathol 2016; 146(4): 423-30.
  64. Gopal S. Moonshot to Malawi. N Engl J Med 2016; 374(17): 1604-5.
  65. Stanley CC, Westmoreland KD, Itimu S, et al. Quantifying bias in survival estimates resulting from loss to follow-up among children with lymphoma in Malawi. Pediatr Blood Cancer 2016.
  66. Sims Sanyahumbi A, Sable CA, Karlsten M, et al. Task shifting to clinical officer-led echocardiography screening for detecting rheumatic heart disease in Malawi, Africa. Cardiol Young 2016: 1-7.
  67. Hobbs CV, Gabriel EE, Kamthunzi P, et al. Malaria in HIV-Infected Children Receiving HIV Protease-Inhibitor- Compared with Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy, IMPAACT P1068s, Substudy to P1060. PLoS One 2016; 11(12): e0165140.
  68. Breast Cancer Screening in Low- and Middle-Income Countries: A Perspective From Malawi. Lily A. Gutnik, Beatrice Matanje-Mwagomba,Vanessa Msosa,Suzgo Mzumara,Blandina Khondowe, Agnes Moses, Racquel E. Kohler, Lisa A. Carey, Clara N. Lee, Satish Gopal JGO published online on December 23, 2015; DOI:10.1200/JGO.2015.000430. http://jgo.ascopubs.org/content/early/2015/12/23/JGO.2015.000430.full
  69. Tang JH, Kopp DM, Stuart GS, O’Shea M, Stanley CC, Hosseinipour MC, Miller WC, Mwale M, Kaliti S, Bonongwe P, Rosenberg NE. Association between contraceptive implant knowledge and implant uptake among postpartum Malawian women: a prospective cohort study. Contraception and Reproductive Medicine 2016:1:13.
  70. Mwafulirwa T, O’Shea M, Hamela G, Samuel E, Chingondole C, Chipangula V, Hosseinipour M, Tang JH. Family planning providers’ experiences and perceptions of long-acting reversible contraception in Lilongwe, Malawi. African Journal of Reproductive Health 2016;20(2):62-71.
  71. Hancock NL, Stuart GS, Tang JH, Chibwesha CJ, Stringer JSA, Chi BH. Renewing focus on family planning service quality globally. Contraception and Reproductive Medicine 2016;1:10.
  72. Groesbeck PP, Mwanahamuntu MH, Hicks ML, Henry-Tillmand R, Chibwesha CJ, Chinula L, Oneko OA, Murokorag D, Sahasrabuddhe VV. Population-level scale-up of surgery platforms for women’s cancer care in low- and middle-income countries. Journal of Cancer Policy. 2016. 7: 23–27. DOI: http://dx.doi.org/10.1016/j.jcpo.2015.12.002